Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Severine Margeridon-Thermet

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Viruses|January 19, 2011
Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis CSeverine Margeridon-Thermet, Robert W Shafer
Plos One|August 21, 2014
Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencingSeverine Margeridon-Thermet, Sophie Le Pogam, Lewyn Li, et al.
Bioinformatics (Oxford, England)|October 13, 2010
A classification model for G-to-A hypermutation in hepatitis B virus ultra-deep pyrosequencing readsElizabeth C Reuman, Severine Margeridon-Thermet, Harrison B Caudill, et al.
Antiviral Research|September 30, 2010
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discoverySoo-Yon Rhee, Severine Margeridon-Thermet, Mindie H Nguyen, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2012
Low-level persistence of drug resistance mutations in hepatitis B virus-infected subjects with a past history of Lamivudine treatmentSeverine Margeridon-Thermet, Evguenia S Svarovskaia, Farbod Babrzadeh, et al.
The Journal of Infectious Diseases|March 24, 2009
Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patientsSeverine Margeridon-Thermet, Nancy S Shulman, Aijaz Ahmed, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Viruses|January 19, 2011
Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis CSeverine Margeridon-Thermet, Robert W Shafer
Plos One|August 21, 2014
Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencingSeverine Margeridon-Thermet, Sophie Le Pogam, Lewyn Li, et al.
Bioinformatics (Oxford, England)|October 13, 2010
A classification model for G-to-A hypermutation in hepatitis B virus ultra-deep pyrosequencing readsElizabeth C Reuman, Severine Margeridon-Thermet, Harrison B Caudill, et al.
Antiviral Research|September 30, 2010
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discoverySoo-Yon Rhee, Severine Margeridon-Thermet, Mindie H Nguyen, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2012
Low-level persistence of drug resistance mutations in hepatitis B virus-infected subjects with a past history of Lamivudine treatmentSeverine Margeridon-Thermet, Evguenia S Svarovskaia, Farbod Babrzadeh, et al.
The Journal of Infectious Diseases|March 24, 2009
Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patientsSeverine Margeridon-Thermet, Nancy S Shulman, Aijaz Ahmed, et al.
Pageof 1